Accession Number: | 0001610618-21-000082 |
Date: | 2021-09-01 |
Issuer: | CIDARA THERAPEUTICS, INC. (CDTX) |
Original Submission Date: |
SHAH PREETAM
6310 NANCY RIDGE DRIVE
SUITE 101
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.22 | 2021-09-01 | deemed execution date | A | 311,850 (a) | 2031-08-31 | common stock 311,850 | $2.22 | 311,850 | direct | ||
RESTRICTED STOCK UNIT | 0.0 | 2021-09-01 | deemed execution date | A | 50,000 (a) | 2022-09-30 | common stock 50,000 | $0.00 | 50,000 | direct |
ID | footnote |
---|---|
f1 | 25% of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of september 1, 2021; 1/48th of the shares subject to the option shall vest monthly thereafter,such that all shares will be vested on september 1, 2025. |
f2 | restricted stock units convert into common stock on a one-for-one basis. |
f3 | the rsu will fully vest upon the completion of certain corporate milestones on or before september 30, 2022. |